Loading…

Jeisys Medical has completed a major expansion of its filler manufacturing facility in Yongin, South Korea, doubling production capacity to 12 million syringes per year (1ml basis). The new line can produce up to 6 million syringes annually. Commercial production is targeted for Q1 2027.
“증설된 생산능력은 연간 최대 600만 실린지(1ml 기준)를 생산할 수 있는 규모로, 증설 완료에 따라 제테마의 의료기기생산본부 전체 필러 생산 능력은 연간 총 1200만(1ml 기준) 실린지에 달하게 된다.”web3.newspim.com
Summarized from public sources; check the original articles before acting on it.